SCHEMBL6171994

SCHEMBL6171994

CC(c1ccncc1C(=O)Oc1ccccc1)C1(C(C)c2ccncc2C(=O)Oc2ccccc2)NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 2/20 0.35
IGF1R P08069 2/20 0.34
NAMPT P43490 1/20 0.33
KMT2A Q03164 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32
THRB P10828 1/20 0.32
MAPT P10636 2/20 0.31
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173899 0.88 ALDH1A1 (0.39) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172647 0.87 CYP3A4 (0.35) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6175647 0.87 ALDH1A1 (0.38) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172569 0.86 IGF1R (0.36) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6177902 0.86 CYP2C9 (0.35) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172103 0.85 RXFP1 (0.42) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6171082 0.83 ALDH1A1 (0.35) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172665 0.83 SLC6A9 (0.38) ALDH1A1LMNAKMT2AMAPTSMN1; SMN2
SCHEMBL6173613 0.82 KIF11 (0.37) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173489 0.81 DPP4 (0.36) ALDH1A1CYP3A4GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed